Screener
IDEAYA Biosciences, Inc. IDYA Contract Assets
Contract Assets at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerAssetNetCurrent.
The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206357
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $157,522 | $112,825 |
| Short-term marketable securities | 513,679 | 526,563 |
| Prepaid expenses and other current assets | 18,346 | 21,366 |
| Contract assets | 6,560 | 5,973 |
| Total current assets | 696,107 | 666,727 |
| Restricted cash | 1,281 | 1,015 |
| Long-term marketable securities | 301,713 | 410,297 |
| Property and equipment, net | 8,634 | 8,217 |
Item 1. Financial Statements (UNAUDITED).
FAQ
- What is IDEAYA Biosciences, Inc.'s contract assets?
- IDEAYA Biosciences, Inc. (IDYA) reported contract assets of $6.56M in Q1 2026.
- What does contract assets mean?
- Revenue recognized under ASC 606 where the right to payment is conditional on something other than the passage of time — work performed but not yet billable.
Ask your AI about IDEAYA Biosciences, Inc.'s contract assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude